Literature DB >> 6938976

Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies.

K F Mitchell, J P Fuhrer, Z Steplewski, H Koprowski.   

Abstract

This report describes the structures of three distinct human melanoma surface antigens detected by monoclonal anti-melanoma antibodies. One antigen, expressed on all melanoma cells and on certain astrocytoma cells but not on any other kind of normal or tumor cell tested, has been shown to consist of our associated polypeptide chains. A second antigen expressed on many but not all melanomas has been identified as the antigenic product of the HLA-D locus, the DR antigen. A third protein antigen is not found on any normal cell tested but occurs on some, but not all, tumors of various origins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6938976      PMCID: PMC350487          DOI: 10.1073/pnas.77.12.7287

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Rabbit antisera to human B cell alloantigens: effects on the mixed lymphocyte response.

Authors:  S S Geier; P Cresswell
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

2.  Epidermal Langerhans cells express Ia antigens.

Authors:  L Klareskog; U Tjernlund; U Forsum; P A Peterson
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cell surface antigens of human melanoma identified by monoclonal antibody.

Authors:  M Y Yeh; I Hellström; J P Brown; G A Warner; J A Hansen; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma.

Authors:  Z Steplewski; M Herlyn; D Herlyn; W H Clark; H Koprowski
Journal:  Eur J Immunol       Date:  1979-01       Impact factor: 5.532

6.  Expression of Ia-like antigens on cultured human malignant melanoma cell lines.

Authors:  R J Winchester; C Y Wang; A Gibofsky; H G Kunkel; K O Lloyd; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes.

Authors:  B C Glovanella; J S Stehlin; C Santamaria; S O Yim; A C Morgan; L J Williams; A Leibovitz; P J Fialkow; D M Mumford
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

8.  Study of antibodies against human melanoma produced by somatic cell hybrids.

Authors:  H Koprowski; Z Steplewski; D Herlyn; M Herlyn
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera.

Authors:  R J Winchester; P A Meyers; H E Broxmeyer; C Y Wang; M A Moore; H G Kunkel
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization.

Authors:  B S Wilson; F Indiveri; M A Pellegrino; S Ferrone
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Vitronectin receptor: tissue specific expression or adaptation to culture?

Authors:  M Horton
Journal:  Int J Exp Pathol       Date:  1990-10       Impact factor: 1.925

2.  Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.

Authors:  D R Vlock; J M Kirkwood
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 3.  Human tumor-associated antigens identified by monoclonal antibodies.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Springer Semin Immunopathol       Date:  1982

Review 4.  Hybridomas: a new dimension in biological analyses.

Authors:  R H Kennett
Journal:  In Vitro       Date:  1981-12

5.  HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.

Authors:  D Guerry; M A Alexander; M F Herlyn; L M Zehngebot; K F Mitchell; C M Zmijewski; E J Lusk
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

6.  Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.

Authors:  B S Wilson; N E Kay; K Imai; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth.

Authors:  T F Bumol; Q C Wang; R A Reisfeld; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis.

Authors:  S Paulie; H Koho; H Ben-Aissa; Y Hansson; M L Lundblad; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.

Authors:  H Koho; S Paulie; H Ben-Aissa; I Jónsdóttir; Y Hansson; M L Lundblad; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.